Metagenomi Therapeutics, Inc. · NASDAQ:MGX
Wein Matthew sold 358 Metagenomi Therapeutics, Inc. shares (Form 4)
Traded Sep 8, 2026 · Filed Sep 10, 2026
On Sep 8, 2026, Wein Matthew (See Remarks) sold 358 Metagenomi Therapeutics, Inc. shares at US$1.16 for US$415, leaving 126,133 shares. Filed Sep 10, 2026 (Form 4).
- Sold
- 358 shares
- Price
- US$1.16
- Value
- US$415
- Holding after
- 126,133 shares
- Trading plan
- No
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Common Stock | Sale | 358 | US$1.16 | 126,133 | Direct |
Source
Related
- Metagenomi Therapeutics, Inc.
- Wein Matthew
- Metagenomi Therapeutics, Inc. shareholders
- Form 4 · Wein Matthew · Jun 10, 2026
- Form 4 · Wein Matthew · Apr 3, 2026
- Form 4 · Reid Laurence · Sep 11, 2026
- Form 4 · Irish Jian · Sep 10, 2026
- Form 4 · Wapnick Pamela · Sep 10, 2026
- Schedule 13G · Thomas Brian C. · Sep 10, 2026
- Form 4 · Wapnick Pamela · Jun 10, 2026